Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Prostate Cancer treatment details. Chemotherapy. Rudolfstiftung, Vienna, Austria

Survival: 11.7 months
Toxicity Grade: 4
Treatments: Chemotherapy
Drugs: Emcyt
Country: Austria
City/State/Province: Vienna
Hospital: Rudolfstiftung
Journal: Link
Date: 1/2004

Patients: This Phase II study involved a total of 90 patients with hormone refractory prostate cancer. Patients were divided into two groups of 45 patients each: Group 1 and Group 2.

Treatment: For patients in Group 2 the treatment consisted of the chemotherapy drug estramustine (emcyt).

Toxicity: Grade 3-4 toxicities included: cardiovascular, diarrhea, nausea, vomiting, neurological, bilirubin rise, and hematologic.

Results: Median survival was 50.9 weeks (11.7 months).

Correspondence: W. Albrecht, MD

E-mail to a Friend Email Physician More Information